Aqara Introduces Presence Sensor FP1E with Enhanced Ease-of-Use
Aqara, a global leader and pioneer in IoT, today announced the launch of the Presence Sensor FP1E, expanding the Company’s smart sensor lineup. Built upon Zigbee protocol, the FP1E sensor is designed for enhanced monitoring and automation capabilities for homeowners while maintaining ease of use. The sensor also supports Matter over an Aqara Matter bridge, and offers seamless compatibility across Matter platforms including Amazon Alexa, Apple Home, Google Home, Home Assistant, Homey, and Samsung SmartThings*.
Utilizing millimeter wave (mmWave) technology, the Presence Sensor FP1E detects even the slightest human movements, allowing for precise, prompt presence detection that can be used for various home automation scenarios. It detects presence within a distance of up to 6 meters (ca. 20 feet), and can monitor a room of up to 50 square meters (ca. 538 sqft) when ceiling mounted. Compared to PIR motion sensors, the FP1E detects human presence even when the person is sitting or lying still. Moreover, it can recognize within seconds when the person leaves a room and trigger the automation to turn off the lights and air conditioner, ultimately reducing energy loss.
As a complement to the versatile Presence Sensor FP2 with a broader feature set, the FP1E is streamlined for enhanced user-friendliness, ideal for those who seek a straightforward yet precise occupancy detection solution without the need for advanced functionalities like zone positioning. Designed for immediate use out of the box, the FP1E sensor uses advanced AI algorithms to distinguish between relevant movements and false triggers, eliminating the hassle of additional setups. Small pets and interference sources such as mirrors, metals, curtains, and ACs are filtered to reduce unnecessary alerts, while the sensor’s sensitivity is self-adaptive. The sensor is also equipped with AI learning capabilities that augment its detection accuracy through continuous learning, adapting to the user’s home environment over time.
Aqara Home users can utilize the FP1E to detect human movement or stillness within a space, unlocking a wide range of automation possibilities triggered by moving/still status along with the status duration. For example, the sensor can detect if the user remained still for over 30 minutes and can send notifications or change the color of the user’s smart lights as a gentle reminder to stand up. This automation aims to promote a healthier routine, reduce the risks of sedentary behavior, and prioritize self-care with visual cues and reminders.
The FP1E is powered by a 5V1A power supply and comes with both a magnetic and adhesive-backed bracket, allowing for effortless installation on walls, ceilings, or corners.
The Presence Sensor FP1E is now available in Aqara’s Amazon brand stores across North America (US, Canada), Europe (France, Germany, Italy, Netherlands, Poland, Spain, UK) and Asia (Japan), as well as through select Aqara retailers worldwide.
For more information on this sensor, please visit our website.
* An Aqara hub is required for use of the Presence Sensor FP1E. A Matter-compatible Aqara hub is required for Matter compatibility.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240806541217/en/
Contacts
For Media Inquiries:
media@aqara.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 10:15:00 EEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 10:00:00 EEST | Press release
Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vice President, Skechers Technical Performance Division. “An evolution of our legacy in running, Skechers AERO was d
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 10:00:00 EEST | Press release
Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP and Optical Transport, Mobile Networks, Mobile Services, and Data Centres. “Network X is more than a conference—it
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 08:00:00 EEST | Press release
4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P004. “Enrolling our first patient is a pivotal step toward rewriting the treatment paradigm for knee osteoarthritis,” said Professor Francis Berenbaum, MD, PhD, Chief Medical Officer at 4Moving Biotech. “Almost 600 million people live with OA, yet no disease-modifying therapy has been done to patients. B
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 20:06:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The company’s global headquarters includes WPC certified test equipment and state-of-the-art test labs dedicated to full product lifecycle validatio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom